Article PDF
References
Spielberg SP, Portman R. New horizons in pediatric drug development. Therapeutic Innovation & Regulatory Science. 2015;49(5):613–614.
Gamalo-Siebers M, Hampson L, Kordy K, et al. Incorporating innovative techniques toward extrapolation and efficient pediatric drug development. Therapeutic Innovation & Regulatory Science. 2019. doi:10.1177/2168479019842541
Liu X, Ward RM. Pharmacometrics in pediatrics. Therapeutic Innovation & Regulatory Science. 2019. doi:10.1177/2168479019851793
Job K, Gamalo-Siebers M, Ward RM. Pediatric age groups and approach to studies. Therapeutic Innovation & Regulatory Science. 2019. doi:10.1177/2168479019856572
Hirschfeld S, Zajicek A. What could the future of safety monitoring look like? Therapeutic Innovation & Regulatory Science. 2019. doi: 10.1177/2168479019854339.
Turner M, Benjamin D, Hovinga C, et al. Pediatric Clinical Research Networks to accelerate development of therapeutics in all pediatric specialties and age groups. Therapeutic Innovation & Regulatory Science. (in prep).
Tsang VWL, West L, Woods C, et al. Role of patients and parents in pediatric drug development. Therapeutic Innovation & Regulatory Science. 2019. doi: 10.1177/2168479018820875.
Yen E, Davis JM, Milne CP. Impact of regulatory incentive programs on the future of pediatric drug development. Therapeutic Innovation & Regulatory Science. 2019. doi:10.1177/2168479019837522
Bucci-Rechtweg CM, Ward RM. Tiny and forgotten: a call for focused neonatal policy reform. Therapeutic Innovation & Regulatory Science. 2019. doi:10.1177/2168479018821922
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McCune, S., Portman, R.J. Innovation and Opportunities in Pediatric Therapeutic Development. Ther Innov Regul Sci 53, 564–566 (2019). https://doi.org/10.1177/2168479019869754
Published:
Issue Date:
DOI: https://doi.org/10.1177/2168479019869754